GlassScriptPhysician profile
Deepthi R Mosali
NPI 1538108881
$3,118.20
in general payments reported to CMS, 2019-2025
18 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $62.04 · 2021: $313 · 2022: $762 · 2023: $1,152 · 2024: $438 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575 · Travel and Lodging: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.84 |
| Travel and Lodging | $250.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,825.95 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Coroflow |
| Medtronic, INC. | $318.49 | 2022-2023 | Reveal Linq |
| Impulse Dynamics (USA) INC. | $171.26 | 2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $164.21 | 2022-2024 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $136.00 | 2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $124.07 | 2020-2022 | |
| Abiomed | $123.73 | 2021-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.14 | 2022-2024 | Lifevest |
| Pfizer INC. | $29.08 | 2022 | |
| Daxor Corporation | $25.06 | 2023 | Bva-100 |
| Boston Scientific Corporation | $23.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.54 | 2023 | Jardiance |
| Vifor Pharma, INC. | $21.12 | 2023 | Veltassa |
| Chiesi USA, INC. | $18.93 | 2024 | Cleviprex, Kengreal |
| Kiniksa Pharmaceuticals, LTD. | $17.41 | 2023 | Arcalyst |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.63 | 2025 | |
| Scpharmaceuticals INC. | $15.73 | 2024 | |
| United Therapeutics Corporation | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepthi Mosali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.